cdmo.directory
← Compare landing

AskBio vs Viralgen

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAskBioViralgen
SummaryAskBio is a clinical-stage gene therapy company developing AAV gene therapies for genetic and rare disorders, with a focus on advancing genetic technology and lowering production costs to increase patient access.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Process Development
  • CMC Analytical Development
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • Analytical Method Development & Validation
Modalities
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Gene Therapy
  • AAV / Viral Vector Platform
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilities
  • Drug Substance (DS)
  • Expression: Viral Vector
Data not yet provided.
Locations
  • Headquarters, Durham, North Carolina, United States
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • FDA · Identifier: Fast Track Designation (AB-1009)
  • FDA · Identifier: Orphan Drug Designation (AB-1009)
  • EMA · Identifier: AEMPS/EMA certified

Find similar companies

AskBio alternatives · Viralgen alternatives

Markdown mirror: /compare/askbio/viralgen.md